Results 51 to 60 of about 6,124 (160)

Granulomatosis with polyangiitis and microscopic polyangiitis: pathogenesis and clinical manifestations

open access: yesСовременная ревматология
This literature review addresses the epidemiology, genetic markers, pathogenesis, clinical features, and diagnostic approaches of granulomatosis with polyangiitis and microscopic polyangiitis – both antineutrophil cytoplasmic antibody-associated ...
T. M. Reshetnyak   +3 more
doaj   +1 more source

Detection of Diagnostic Antibodies in Immune‐Mediated Diseases: A Focus on Antigens and Technologies

open access: yesChemBioChem, Volume 27, Issue 9, 14 May 2026.
This review explores autoantibody detection in immune‐mediated diseases, highlighting autoantigens including post‐translational modifications. We compared enzyme‐linked immunosorbent assay and indirect immunofluorescence with automated chemiluminescence platforms.
Silvia Bracci   +5 more
wiley   +1 more source

Risk Factors for Relapse in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis Among Patients With Relapse After Induction of Remission With Rituximab

open access: yesArthritis &Rheumatology, Volume 78, Issue 5, Page 1134-1144, May 2026.
Objective The objective of the study was to determine risk factors for relapse of antineutrophil cytoplasmic antibody (ANCA)–associated vasculitis (AAV) after reinduction of remission with rituximab and discontinuation of maintenance therapy. Methods This is a post hoc analysis of the RITAZAREM clinical trial.
Ellen Romich   +62 more
wiley   +1 more source

Ultra-Wide-Field Fluorescein Angiography in Microscopic Polyangiitis

open access: yesCase Reports in Ophthalmological Medicine, 2016
A 25-year-old Hispanic female presented with 5 months of dry eyes and 2 months of bilateral photophobia and decreased vision. On examination, she had bilateral anterior uveitis and mild disc edema of the left eye.
Philip P. Storey   +4 more
doaj   +1 more source

The Current Use and Future Perspectives of Biosimilars in Pediatric Healthcare: A Narrative Review

open access: yesHealth Science Reports, Volume 9, Issue 5, May 2026.
ABSTRACT Background and Aims The integration of biosimilars into pediatric healthcare represents a significant evolution in treatment accessibility and cost‐effectiveness. Biosimilars—biological products highly similar to already approved biologics, have emerged as promising alternatives for managing chronic and rare pediatric conditions, including ...
Zubaier Ahmed   +6 more
wiley   +1 more source

Intracerebral hemorrhage after IV tPA for stroke as early symptom of ANCA-associated vasculitis

open access: yeseNeurologicalSci, 2017
Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitides (AAV) are rare diseases characterized by a necrotizing small-vessel vasculitis and circulating ANCA that comprise granulomatosis with polyangiitis, microscopic polyangiitis, and ...
Neda Zarghami Esfahani   +3 more
doaj   +1 more source

Rituximab in Kidney-Limited Microscopic Polyangiitis

open access: yesTranslation, 2023
Anvitha Madhavaram, Nezam Altorok
doaj   +1 more source

Microscopic Polyangiitis with Pulmonary Fibrosis: An Often-Recognized Manifestation of the Disease

open access: yesCase Reports in Rheumatology, 2019
Background. Microscopic polyangiitis (MPA) can manifest with atypical features such as pulmonary fibrosis and chronic obstructive pulmonary disease (COPD), which are atypical and unusual features of small vessel vasculitis. Case Presentation.
Liam M. Clifford   +3 more
doaj   +1 more source

A Rare Case of Anti Neutrophil Cytoplasmic Antibody Associated Vasculitis Presenting as Pyelonephritis [PDF]

open access: yesJournal of Clinical and Diagnostic Research
Anti-Neutrophil Cytoplasmic Antibody (ANCA) Associated Vasculitis (AAV) is a condition affecting small and medium-sized vessels, predominantly impacting the kidneys.
Chetan Phadke, Shreeharsh Godbole
doaj   +1 more source

Microscopic Polyangiitis [PDF]

open access: yes, 2008
Nestor L. Müller, C. Isabela S. Silva
  +4 more sources

Home - About - Disclaimer - Privacy